Literature DB >> 20080292

Classification system: organ preserving treatment for prostate cancer.

John F Ward1, J Stephen Jones.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20080292     DOI： 10.1016/j.urology.2009.10.044

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  7 in total

Review 1.  Contemporary outcomes of focal therapy in prostate cancer: what do we know so far...

Authors:  John F Ward
Journal:  World J Urol       Date:  2010-08-03       Impact factor: 4.226

Review 2.  Image guidance for focal therapy of prostate cancer.

Authors:  U Lindner; N Lawrentschuk; J Trachtenberg
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

Review 3.  Focal therapy in prostate cancer: modalities, findings and future considerations.

Authors:  Uri Lindner; John Trachtenberg; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-09-14       Impact factor: 14.432

Review 4.  Considerations for patient selection for focal therapy.

Authors:  John F Ward; Louis L Pisters
Journal:  Ther Adv Urol       Date:  2013-12

5.  Single application of high-intensity focused ultrasound as primary therapy of localized prostate cancer: Treatment-related predictors of biochemical outcomes.

Authors:  Dietrich Pfeiffer; Juergen Berger; Andreas Gross
Journal:  Asian J Urol       Date:  2015-04-16

Review 6.  Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?-a narrative review.

Authors:  Antony Pellegrino; Giuseppe O Cirulli; Elio Mazzone; Francesco Barletta; Simone Scuderi; Mario de Angelis; Giuseppe Rosiello; Giorgio Gandaglia; Francesco Montorsi; Alberto Briganti; Armando Stabile
Journal:  Ann Transl Med       Date:  2022-07

7.  Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus.

Authors:  Amir H Lebastchi; Arvin K George; Thomas J Polascik; Jonathan Coleman; Jean de la Rosette; Baris Turkbey; Bradford J Wood; Michael A Gorin; Abhinav Sidana; Sangeet Ghai; Kae Jack Tay; John F Ward; Rafael Sanchez-Salas; Berrend G Muller; Bernard Malavaud; Pierre Mozer; Sebastien Crouzet; Peter L Choyke; Osamu Ukimura; Ardeshir R Rastinehad; Peter A Pinto
Journal:  Eur Urol       Date:  2020-06-10       Impact factor: 20.096
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.